[MDGL] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
10-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- 38.08%
YoY- 68.49%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -15,080 -6,364 -5,999 -6,524 -20,707 -23,557 -20,728 -5.16%
Tax 0 0 0 0 0 0 0 -
NP -15,080 -6,364 -5,999 -6,524 -20,707 -23,557 -20,728 -5.16%
Tax Rate - - - - - - - -
Total Cost 15,080 6,364 5,999 6,524 20,707 23,557 20,728 -5.16%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS -0.98 -0.45 -0.50 -37.03 -6.69 -9.65 -10.52 -32.65%
EPS Diluted -0.98 -0.45 -0.50 -37.03 -6.69 -9.65 -10.52 -32.65%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.